Related Experiment Video

Updated: Aug 7, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Targeted therapies in non-small cell lung cancer: proven concepts and unfulfilled promises

Jutta Auberger1, Judith Loeffler-Ragg, Walter Wurzer

  • 1Department of Internal Medicine, Division of Hematology and Oncology, Medical University Innsbruck, Austria.

Current Cancer Drug Targets
|July 20, 2006
PubMed

Insights

Targeted cancer therapies, including anti-EGFR and anti-VEGF treatments, show promise but require proper patient selection. Predictive markers are crucial for the effective and economical use of these novel oncogenesis-targeting agents in clinical practice.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Targeted therapies revolutionize cancer treatment by focusing on specific molecular pathways involved in oncogenesis.
  • Major targets include the epidermal growth factor receptor (EGFR)-family, angiogenesis, and signaling pathways like PKC/Ras/MAPK.

Purpose of the Study:

  • To review current knowledge on targeted therapies in non-small cell lung cancer (NSCLC).
  • To discuss the therapeutic potential and implementation challenges of targeted agents.

Main Methods:

  • Review of phase I, II, and III clinical trials.
  • Analysis of targeted therapy approaches affecting key cancer signaling pathways.

Main Results:

  • Anti-EGFR and anti-VEGF therapies have demonstrated efficacy in phase III trials.
  • Other targeted agents (e.g., PKC inhibitors) have faced challenges, highlighting the need for proper patient stratification.
  • Successful clinical integration hinges on identifying robust predictive markers.

Conclusions:

  • Targeted therapies offer significant potential in NSCLC treatment.
  • Optimizing patient selection and treatment sequencing is critical for maximizing efficacy and ensuring cost-effectiveness.
  • Further research into predictive markers is essential for routine clinical application.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.